Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Circulation 2017 Nov 13;[EPub Ahead of Print], KW Mahaffey, B Neal, V Perkovic, D de Zeeuw, G Fulcher, N Erondu, W Shaw, E Fabbrini, T Sun, Q Li, M Desai, DR MatthewsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.